ARTICLE | Financial News
Xcyte files for IPO
December 22, 2000 8:00 AM UTC
Xcyte Therapies (Seattle, Wash.), which is developing its Xcellerate Technology to activate and grow a patient's T cells ex vivo, filed to raise up to $86.3 million in an IPO. The deal will be underwr...